Download:
pdf |
pdfAttachment 2. Traceable Opioid Material* Kits Questions
Form Approved
OMB No. 0923-0047
Exp. Date 01/31/2022
Traceable Opioid Material* Kit Questions
Please provide the information below so that your request can be processed quickly.
1. Which of the following best describes your laboratory? (Select only one)
Academic Research Laboratory
Environmental Laboratory
Government Crime Laboratory
Government Toxicology Laboratory
Private or Public Clinical Laboratory
Other (please specify) _____________________________________
2. Which of the following tests or services are performed by your laboratory? (Select all that apply)
Seized drug sample testing
Post-mortem toxicology sample testing
Workplace drug screening
Newborn drug screening
Drug pharmacology and pharmacokinetics research
Clinical testing for disease diagnosis and treatment or surveillance
Other __________________________________________________
3. On average, how many opioid-related samples does your laboratory analyze on a weekly basis?
<100
101-500
501-1000
>1000
--------------------------------------------------------------------------------------------------------------------------4. Which of the following analytical techniques do you perform in your laboratory?
(Select all that apply)
Immunoassay
Infrared Spectroscopy
Mass Spectrometry
Nuclear Magnetic Resonance Spectroscopy
Raman Spectroscopy
X-ray Diffraction
Chromatographic Separation
UV/Vis
Other (please specify) _____________________________________
5. Which matrix type does your laboratory analyze? (Select all that apply)
Blood
Urine
Other (please specify) _____________________________________
6. What sample sizes are being tested? (Select all that apply)
<0.1 mL
0.1- 0.5 mL
>0.5 mL
Other (please specify) _____________________________________
*TRACEABLE OPIOID MATERIAL, TOM KITS, and the TOM KITS logo are marks of the U.S. Department of Health and Human Services.
CDC estimates the average public reporting burden for this collection of information as 6 minutes per response, including the time for reviewing
instructions, searching existing data/information sources, gathering and maintaining the data/information needed, and completing and
reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of
information unless it displays a currently valid OMB Control Number. Send comments regarding this burden estimate or any other aspect of this
collection of information, including suggestions for reducing this burden to CDC/ATSDR Information Collection Review Office, 1600 Clifton Road
NE, MS D-74, Atlanta, Georgia 30333; ATTN: PRA (0923-0047).
File Type | application/pdf |
File Modified | 0000-00-00 |
File Created | 0000-00-00 |